Substitution has better efficacy than add-on therapy for patients with focal epilepsy after their first antiepileptic drug treatments fail
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 64, 23-28
Abstract
No abstract availableKeywords
Funding Information
- Epilepsy Research Fund of China Association Against Epilepsy (2017004)
- Zhejiang Provincial Natural Science Foundation of China (LY15H090015)
This publication has 32 references indexed in Scilit:
- Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromesEpilepsia, 2013
- Truly “Rational” Polytherapy: Maximizing Efficacy and Minimizing Drug Interactions, Drug Load, and Adverse EffectsCurrent Neuropharmacology, 2009
- Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy [RETIRED]Neurology, 2004
- Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trialEpilepsy Research, 2003
- Management of epilepsy in adolescents and adultsThe Lancet, 2000
- Remission of epilepsy: results from the National General Practice Study of EpilepsyThe Lancet, 1995
- Reduction of Polypharmacy in Epileptic PatientsArchives of Neurology, 1985
- Reduction of Two‐Drug Therapy in Intractable EpilepsyEpilepsia, 1983
- Reduction in polypharmacy for epilepsy.BMJ, 1979
- Unnecessary polypharmacy for epilepsy.BMJ, 1977